Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
about
Opioid overdose prevention and naloxone rescue kits: what we know and what we don't knowPrescription opioid poisoning across urban and rural areas: identifying vulnerable groups and geographic areasThe Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.Exploring social work student education: The effect of a harm reduction curriculum on student knowledge and attitudes regarding opioid use disorders.Secular trends in opioid prescribing in the USA.Provider and patient perspectives on opioids and alternative treatments for managing chronic pain: a qualitative study.Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013.Intravenous Heroin Induces Rapid Brain Hypoxia and Hyperglycemia that Precede Brain Metabolic Response.Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically.State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence.Nonmedical use of prescription drugs in adolescents and young adults: not just a Western phenomenon.Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.Treatment utilization among persons with opioid use disorder in the United States.High risk of overdose death following release from prison: variations in mortality during a 15-year observation period.Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.Racial/Ethnic Differences in Prevalence Trends for Heroin use and Non-Medical use of Prescription Opioids Among Entrants to Opioid Treatment Programs, 2005-2016.Fentanyl-Induced Brain Hypoxia Triggers Brain Hyperglycemia and Biphasic Changes in Brain Temperature.Anti-nociceptive action of peripheral mu-opioid receptors by G-beta-gamma protein-mediated inhibition of TRPM3 channels.Utilization of buprenorphine and methadone among opioid users who inject drugs.Heroin use onset among nonmedical prescription opioid users in the club scene.The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment.Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program.To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients.Cost-effectiveness of subdermal implantable buprenorphine versus sublingual buprenorphine to treat opioid use disorder.Revisiting the 'paradigm shift' in opioid use: Developments and implications 10 years later.Trends in Medical and Nonmedical Use of Prescription Opioids Among US Adolescents: 1976-2015.Clues to the Opioid Crisis in Monitoring the Future but Still Looking for Solutions.How States Are Tackling the Opioid Crisis.Nonmedical Use of Prescription Opioids and Heroin Use Among Adolescents Involved in Competitive Sports.Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder.Down in the valley: Trajectories of injection initiation among young injectors in California's Central Valley.Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis.Sex differences in prescription opioid use.Methadone Prescribing and Overdose and the Association with Medicaid Preferred Drug List Policies - United States, 2007-2014.Changes in US Lifetime Heroin Use and Heroin Use Disorder: Prevalence From the 2001-2002 to 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions.
P2860
Q28365114-F29B5E08-AE1C-4A19-9554-D18F4EDFD1E6Q28396203-4F20C7B0-2A5E-4A25-9D71-10BFA6E8E33DQ30396983-C0A82231-A6BC-40E8-B206-ADBBC67C7951Q30402982-55E966FE-5BE7-4495-A1AA-C30CDE0151CFQ30839446-976C93C5-8278-4EEC-862B-CD23566C8915Q30845187-4E81BF9F-0A8E-4A2C-9A71-77E56FCA6384Q31130502-5392611B-EB9F-4B1C-89AB-A5DF0BBC0FA5Q33771081-7564C958-0310-4DDE-8383-61625F3F8D6AQ37125736-E891F0AF-080C-4317-B717-D38F40118A6EQ37176778-4E930F91-14FA-46D7-9D3A-95F03E366308Q37404465-10BE74E3-41A7-471F-9F1B-4E0379069A37Q37549535-8FB1AB60-EA19-4EA0-A478-590D3904D76FQ37609176-642414DD-8DEA-4D60-A7DC-D36C2846004FQ37655493-E82F93D7-B294-408E-B510-E3ED545E8D8EQ38376069-99068128-9416-416B-B8F3-791438FBD518Q38402158-1BEFEB78-6AAD-4CDF-8FBD-07AA9A70F49BQ38429650-211B3A0B-95C4-4AB1-958D-9BD0B628C772Q38602295-AA3C0167-BE19-414C-A7D8-10277E9A3658Q38604165-87CACEDE-BE9F-412D-A3D8-843CF6387EC2Q38615910-75A94BC9-03DA-4385-ABBE-93F1CF36EB93Q38630550-2A80E47D-5F91-49FF-A9DB-B45AEB190217Q38643889-D91F9056-2E52-4986-856E-5D647E378315Q38655953-F51528C3-6BC8-42EE-BEBB-07A2EA68EE06Q38672215-8AAE01E9-2387-4624-B8A4-A65A84DEDC78Q38673634-CF57101F-0042-47E9-88DF-D5C4477D159AQ38688434-3E35312D-5173-48E8-8865-B108D10B7FD6Q38707436-22CE8FAD-6114-4EF0-A5DD-6C723699AE3DQ38711778-D75D672E-E978-4DD2-9BFE-26BC03875B40Q38730784-44BC5E27-3780-4313-8399-F28DB67CEF1BQ38740906-2BF2842F-C5F1-42E4-91FA-ADAD0B80AEF2Q38742659-65120BFF-4E60-414C-B4FB-A1B932DCDC6BQ38742662-F69037B9-A0A0-45B7-8661-F4308B800CF8Q38762786-74476D18-CCF6-4A07-ACE2-9D7C492147A7Q38787577-8FC9D355-F014-49E1-9E2B-813FB918230DQ38798292-61B47699-A60D-40BB-981D-315DD751D1AFQ38811829-9A78D37D-DB55-40D0-814D-9D0344ACD1A5Q38814243-F9A28A34-C7A9-4199-BF80-EB3C941A5842Q38828608-3FA52826-5711-4887-A15B-FE292370EF11Q38867158-8A35632F-3AA3-4894-8DE8-1C352C6D718DQ38868926-2E499C86-73A5-4013-92B1-A469DA3B3508
P2860
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@ast
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@en
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@nl
type
label
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@ast
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@en
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@nl
prefLabel
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@ast
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@en
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@nl
P2093
P3181
P356
P1476
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
@en
P2093
Christopher M Jones
Grant T Baldwin
Wilson M Compton
P304
P3181
P356
10.1056/NEJMRA1508490
P407
P577
2016-01-14T00:00:00Z